CSO Pricing Models: What You'll Actually Pay in 2026

Nobody publishes their rates. That is the first thing you learn when you start pricing contract sales organizations. Amplity will not put a number on a website. Neither will IQVIA or Syneos. You have to sit through two discovery calls and a capabilities deck before anyone hands you a spreadsheet.

I have reviewed 14 CSO proposals since 2023, across pharma, device, and two diagnostics companies. The pricing structures fall into three buckets. The spread between the cheapest and most expensive way to field the same rep is wider than most VPs expect, and the expensive option is not always the one with the bigger sticker.

Model 1: Dedicated FTE pricing

The traditional CSO model. You pay a monthly fee per rep, fully loaded. The rep works your product exclusively, wears your badge, and follows your playbook.

Across the proposals I have seen, dedicated FTE pricing ran from $17,400 to $23,100 per rep per month for pharma primary care, and higher for specialty. That covers salary, benefits, fleet or car allowance, the CSO's management layer, and margin. Annualized, one rep costs you $209K to $277K before you have paid for samples, data, or a CRM seat.

What the sticker does not show: minimum team sizes. Most large CSOs will not deploy fewer than 8 to 10 reps. If you have three vacant territories, this model was not built for you. The economics only work at scale, and the contracts are written to keep you at scale, with 12 to 24 month terms and early termination fees that typically run 60 to 90 days of fees per rep.

Model 2: Hourly contract reps

The marketplace model. You engage individual 1099 contractors at an hourly rate, scoped to the hours you actually need. In the contracts I have reviewed, experienced medical sales contractors billed $85 to $135 per hour depending on specialty and relationship depth, with physician liaison work at the lower end and interventional device support at the top.

A contractor working 20 hours a week at $105 costs you roughly $109K a year. A contractor working 40 hours costs $218K, which lands in the same range as the dedicated FTE model. The difference is you are not locked into 40 hours, ten reps, or 18 months. You buy coverage in the increments the territory actually justifies.

The tradeoff is management. A CSO gives you a regional manager as part of the fee. With contractors, oversight is your job, or the marketplace's, depending on the platform. If your team has no bandwidth to manage anyone, priced-in management has real value. Pay for it knowingly, not by default.

Model 3: Commission-heavy structures

Some smaller CSOs and independent rep groups pitch low fixed cost with commission on sales. On paper this looks like free money. You pay only for results.

Two problems. The first is economic: any rep good enough to live on commission will concentrate on your easiest accounts and ignore territory development, because that is what the structure pays them to do. The second problem is legal, and it is not small. If your product touches federal healthcare program business, percentage-of-sales compensation to 1099 reps sits squarely in Anti-Kickback Statute territory (42 U.S.C. § 1320a-7b(b)). The OIG has called commission arrangements with independent contractors a longstanding concern (Advisory Opinion 06-02). The 2025 Sorensen decision in the 7th Circuit held these arrangements are not automatically illegal when the rep has no real influence over clinical decisions, but the court also noted they remain attractive targets for enforcement.

Hourly billing at fair market value, set in advance, is the structure the personal services safe harbor (42 C.F.R. § 1001.952(d)) was written to protect. I covered the details in the safe harbor guide. If a CSO proposes commission-based 1099 comp for a federally reimbursed product and does not raise the AKS in the first conversation, that tells you something about their compliance function.

The fees that do not appear on page one

Every dedicated FTE proposal I have reviewed included at least two of these below the headline rate. Add them up before you compare anything.

Implementation fees came in between $40K and $150K for team builds, covering recruiting, onboarding, and training design. Data and reporting fees ran $1,500 to $4,000 a month for dashboards you would reasonably assume were included. Recruiting replacement fees appeared in about half the contracts, charging you again when a rep quits, on top of the vacancy you eat while the backfill runs. And several contracts included annual rate escalators of 3 to 5% that compound quietly in year two.

The math is not complicated. A 10-rep dedicated team at $20K a month is $2.4M a year on the sticker. With implementation, data fees, and one round of replacements, the real first-year number is closer to $2.7M. That 12% gap is where CSO margin hides.

What to do with this

If you need 10 or more reps for 18 or more months and you want management handled, dedicated FTE pricing is defensible. Negotiate the implementation fee (it moves), cap the escalator, and get replacement recruiting included.

If you need one to five territories covered, or you need specialty relationships a generalist team will not have, the hourly contractor model is cheaper, faster to stand up, and structurally cleaner on compliance. That segment is where the CSO comparison gets interesting, because the large CSOs do not really compete for it.

And if the pitch is commission-heavy with a 1099 workforce on a federally reimbursed product, walk. The enforcement risk is not worth the fixed-cost savings.

I wrote a broader breakdown of the build-vs-outsource decision in the medical sales outsourcing guide, and a due diligence checklist in how to evaluate a pharma CSO.